Zentynel: A specialized investment group accelerating growth in Latin American biotech startups.
4
Operating
2020
Santiago, Santiago Metropolitan Region, CL
Zentynel Frontier Investments specializes in biotechnology startups, focusing on Latin American companies. The firm typically invests in early-stage rounds, including pre-seed, seed, angel, and Series A. Zentynel aims to accelerate the development and growth of biotech initiatives by providing both capital and industry expertise.
Notable portfolio companies include Autem Therapeutics, Harmony Baby Nutrition, and Respira Labs. Zentynel was formed through a collaboration between Fundación Ciencia y Vida (FCV) and Venturance Alternative Assets. The firm's key partners, including Pablo Valenzuela, Bernardita Méndez, and Cristián Hernández, bring valuable experience to support their portfolio companies in the biotech sector.
Portfolio Snapshot
Recorded participation and recipient operating status, not current holdings or realized exits
Recorded Recipients3
Repeat Participations1
Operating Recipients3
Top Investment Stages
Angel1 (25.0%)
Pre-Seed1 (25.0%)
Seed1 (25.0%)
Series A1 (25.0%)
Stage Mix
Angel 25%Pre-Seed 25%Seed 25%Series A 25%
Concentration shown as share of disclosed investments by stage.
